---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024548"
form_type: "8-K/A"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:15:42.119454+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MyMD Pharmaceuticals files 8-K/A to correct terms of ~$13.9M private placement of preferred stock and warrants

## Summary
- Corrected typographical errors in terms of Series G and Series F-1 Preferred Stock and Warrants from May 20, 2024 private placements.
- Private placements expected to raise approx. $13.9M gross ($8.9M Series G, $5.0M Series F-1).
- Preferred stock convertible at $1.816/share, with 10% annual dividend; redemption beginning Dec 2024.
- Company must hold stockholder meeting by Aug 1, 2024 to seek approval for share issuance above 19.99% and increase authorized shares.
- Net proceeds to be used for general corporate purposes.

## SEC filing metadata
- accession: 0001493152-24-024548
- form_type: 8-K/A
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315224024548/0001493152-24-024548-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315224024548/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024548
- JSON: https://secwatch.observer/filing/0001493152-24-024548.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024548.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.